C-terminal extension of the MHC class II-associated invariant chain by an antigenic sequence triggers activation of naive T cells

Gene Therapy

Volumn 6, Issue 11, 1999, Pages 1826-1834

  Sponaas, A M ^a   Carstens, C ^a   Koch, N ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Antigen presentation; Antigen processing; Dendritic cells; Gene transfer; MHC; Recombinant antigen

Indexed keywords

COMPLEMENTARY DNA; HYBRID PROTEIN; INTERLEUKIN 2; LYSOZYME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE RECEPTOR;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DENDRITIC CELL; DNA TRANSFECTION; GENE TRANSFER; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS;

EID: 0032728423     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301021     Document Type: Article

References (52)

1. Stockinger B et al. A role of Ia-associated invariant chains in antigen processing and presentation. Cell 1989; 56: 683-689.
2. Cresswell P. Invariant chain structure and MHC class II function. Cell 1996; 84: 505-507.
3. Martin WD et al. H2-M mutant mice are detective in the peptide loading of class II molecules, antigen presentation, and T cell repertoire selection. Cell 1996; 84: 543-550.
4. Denzin LK, Cresswell P. HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading. Cell 1995; 82: 155-165.
5. Liljedahl M et al. Altered antigen presentation in mice lacking H2-O. Immunity 1998; 8: 233-243.
6. Riese RJ et al. Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. Immunity 1996; 4: 357-366.
7. Nakagawa T et al. Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus. Science 1998; 280: 450-453.
8. Villadangos JA et al. Degradation of mouse invariant chain: roles of cathepsins S and D and the influence of major histocompatibility complex polymorphism. J Exp Med 1997; 186: 549-560.
9. Tulp A et al. Isolation and characterization of the intracellular MHC class II compartment. Nature 1994; 369: 120-126.
10. Avva RR, Cresswell P. In vivo and in vitro formation and dissociation of HLA-DR complexes with invariant chain-derived peptides. Immunity 1994; 1: 763-774.
11. Kropshofer H et al. HLA-DM acts as a molecular chaperone and rescues empty HLA-DR molecules at lysosomal pH. Immunity 1997; 6: 293-302.
12. Peters PJ et al. Major histocompatibility complex class II compartments in human B lymphoblastoid cells are distinct from early endosomes. J Exp Med 1995; 182: 325-334.
13. Boon T, Coulie PG, Van den Eynde B. Tumor antigens recognized by T cells. Immunol Today 1997; 18: 267-268.
14. Schuler G, Steinman RM. Dendritic cells as adjuvants for immune-mediated resistance to tumors. J Exp Med 1997; 186: 1183-1187.
15. Bot A et al. Kinetics of generation and persistence on membrane class II molecules of a viral peptide expressed on foreign and self proteins. J Immunol 1996; 157: 3436-3442.
16. Zaghouani H et al. Presentation of a viral T cell epitope expressed in the CDR3 region of a self immunoglobulin molecule. Science 1993; 259: 224-227.
17. Darji A et al. Oral somatic transgene vaccination using attenuated S. typhimurium. Cell 1997; 91: 765-775.
18. Kozono H et al. Production of soluble MHC class II proteins with covalently bound single peptides. Nature 1994; 369: 151-154.
19. Parra Lopez CA et al. Presentation on class II MHC molecules of endogenous lysozyme targeted to the endocytic pathway. J Immunol 1997; 158: 2670-2679.
20. Sanderson S, Frauwirth K, Shastri N. Expression of endogenous peptide-major histocompatibility complex class II complexes derived from invariant chain-antigen fusion proteins. Proc Natl Acad Sci USA 1995; 92: 7217-7221.
21. Nakano N, Rooke R, Benoist C, Mathis D. Positive selection of T cells induced by viral delivery of neopeptides to the thymus. Science 1997; 275: 678-683.
22. van Bergen J et al. Efficient loading of HLA-DR with a T helper epitope by genetic exchange of CLIP. Proc Natl Acad Sci USA 1997; 94: 7499-7502.
23. Malcherek G et al. MHC class II-associated invariant chain peptide replacement by T cell epitopes: engineered invariant chain as a vehicle for directed and enhanced MHC class II antigen processing and presentation. Eur J Immunol 1998; 28: 1524-1533.
24. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392: 245-252.
25. Steinman RM. The dendritic cell system and its role in immunogenicity. Ann Rev Immunol 1991; 9: 271-296.
26. Kämpgen E et al. Class II major histocompatibility complex molecules of murine dendritic cells: synthesis, sialylation of invariant chain, and antigen processing capacity are down-regulated upon culture. Proc Natl Acad Sci USA 1991; 88: 3014-3018.
27. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994; 179: 1109-1118.
28. Freisewinkel IM, Schenck K, Koch N. The segment of invariant chain that is critical for association with major histocompatibility complex class II molecules contains the sequence of a peptide eluted from class II polypeptides. Proc Natl Acad Sci USA 1993; 90: 9703-9706.
29. Bertolino P et al. Deletion of a C-terminal sequence of the class II-associated invariant chain abrogates invariant chains oligomer formation and class II antigen presentation. J Immunol 1995; 154: 5620-5629.
30. Bakke O, Dobberstein B. MHC class II-associated invariant chain contains a sorting signal for endosomal compartments. Cell 1990; 63: 707-716.
31. Nelson CA, Viner NJ, Unanue ER. Appreciating the complexity of MHC class II peptide binding: lysozyme peptidc and I-Ak. Immunol Rev 1996; 151: 81-105.
32. Boniface JJ et al. Initiation of signal transduction through the T cell receptor requires the multivalent engagement of peptide/MHC ligands. Immunity 1998; 9: 459-466.
33. Rötzschke O, Falk K, Strominger JL. Superactivation of an immune response triggered by oligomerized T cell epitopes. Proc Natl Acad Sci USA 1997; 94: 14642-14647.
34. Akbari O et al. DNA vaccination: transfection and activation of dendritic cells as key events for immunity. J Exp Med 1999; 189: 169-178.
35. Busch R, Strang G, Howland K, Rothbard JB. Degenerate binding of immunogenic peptides to HLA-DR proteins on B cell surfaces. Int Immunol 1990; 2: 443-451.
36. Maurer D et al. Fcepsilon receptor I on dendritic cells delivers IgE-bound multivalent antigens into a cathepsin S-dependent pathway of MHC class II presentation. J Immunol 1998; 161: 2731-2739.
37. Larsen CP et al. Migration and maturation of Langerhans cells in skin transplants and explants. J Exp Med 1990; 172: 1483-1493.
38. Chattergoon MA, Robinson TM, Boyer JD, Weiner DB. Specific immune induction following DNA-based immunization through in vivo transfection and activation of macrophages/antigen-presenting cells. J Immunol 1998; 160: 5707-5718.
39. Inaba K et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 1992; 176: 1693-1702.
40. Pierre P, Mellman I. Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells. Cell 1998; 93: 1135-1145.
41. Siebenkotten IM, Carstens C, Koch N. Identification of a sequence that mediates promiscuous binding of invariant chain to MHC class II allotypes. J Immunol 1998; 160: 3355-3362.
42. Landais D et al. The assignment of chain specificities for anti-la monoclonal antibodies using L cell transfectants. J Immunol 1986; 137: 3002-3005.
43. Koch N, Koch S, Hämmerling GJ. Ia invariant chain detected on lymphocyte surfaces by monoclonal antibody. Nature 1982; 299: 644-645.
44. Lanier LL et al. Monoclonal antibodies against rat immunoglobulin kappa chain. Hybridoma 1982; 1: 125-131.
45. Serwe M et al. Both invariant chain isoforms Ii31 and Ii41 promote class II antigen presentation. Int Immunol 1997; 9: 983-991.
46. Inaba K et al. The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J Exp Med 1994; 180: 1849-1860.
47. Allen PM, Matsueda GR, Haber E, Unanue ER. Specificity of the T cell receptor: two different determinants are generated by the same peptide and the I-Ak molecule. J Immunol 1985; 135: 368-373.
48. Calin Laurens V et al. Cytosolic targeting of hen egg lysozyme gives rise to a short-lived protein presented by class I but not class II major histocompatibility complex molecules. Eur J Immunol 1991; 21: 761-769.
49. Rose JK, Buonocore L, Whitt MA. A new cationic liposome reagent mediating nearly quantitative transfection of animal cells. Bio Techniques 1991; 10: 520-525.
50. Tang MX, Redemann CT, Szoka FC Jr. In vitro gene delivery by degraded polyamidoamine dendrimers. Bioconjugate Chem 1996; 7: 703-714.
51. Viville S et al. Mice lacking the MHC class II-associated invariant chain. Cell 1993; 72: 635-648.
52. Ho WY, Cooke MP, Goodnow CC, Davis MM. Resting and anergic B cells are defective in CD28-dependent costimulation of naive CD4+ T cells. J Exp Med 1994; 179: 1539-1549.